KR20090078013A - Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea - Google Patents
Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea Download PDFInfo
- Publication number
- KR20090078013A KR20090078013A KR1020080003762A KR20080003762A KR20090078013A KR 20090078013 A KR20090078013 A KR 20090078013A KR 1020080003762 A KR1020080003762 A KR 1020080003762A KR 20080003762 A KR20080003762 A KR 20080003762A KR 20090078013 A KR20090078013 A KR 20090078013A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- hypoglycemic
- functional
- mushroom mycelium
- leaf tea
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 24
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 16
- 244000269722 Thea sinensis Species 0.000 claims abstract description 16
- 235000013616 tea Nutrition 0.000 claims abstract description 13
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 7
- 235000009569 green tea Nutrition 0.000 claims abstract description 3
- 210000001364 upper extremity Anatomy 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 238000010612 desalination reaction Methods 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 7
- 235000019640 taste Nutrition 0.000 abstract description 7
- 235000012000 cholesterol Nutrition 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 240000000249 Morus alba Species 0.000 abstract description 5
- 235000008708 Morus alba Nutrition 0.000 abstract description 5
- 235000008216 herbs Nutrition 0.000 abstract description 5
- 235000019629 palatability Nutrition 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract description 2
- 229920002498 Beta-glucan Polymers 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 abstract 1
- 235000013325 dietary fiber Nutrition 0.000 abstract 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract 1
- 235000020542 functional tea Nutrition 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract 1
- 235000005493 rutin Nutrition 0.000 abstract 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract 1
- 229960004555 rutoside Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 4
- 244000018633 Prunus armeniaca Species 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- -1 etc.) Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/40—Tea flavour; Tea oil; Flavouring of tea or tea extract
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양 상엽차는 혈당저하 기능 및 혈압강하 등의 유효성분이 들어 있는 상엽(뽕나무 잎), 상지(뽕나무 가지), 상실(뽕나무 열매, 오디) 등과 홍삼, 산약, 천화분 등 한약재를 첨가하고 상황버섯(Phellinus Linteus) 균사체를 고체배양시켜 혼합함으로서 혈당강하, 콜레스테롤 저하 효과가 극대화된 기능성 상엽차에 관한 것이다.Hypoglycemic functional situation mushroom mycelium culture upper leaf tea according to the present invention is the upper leaf (mulberry leaves), upper limbs (mulberry branches), loss (mulberry fruit, mulberry) and red ginseng, mountain medicine, natural flower containing active ingredients such as hypoglycemic function and lowering blood pressure By adding the herbal medicine and the culture of the Phellinus Linteus mycelium solid cultures, the hypoglycemic effect, cholesterol lowering effect maximized functional upper tea.
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양 상엽차는 상목(뽕나무)의 열매, 잎, 줄기, 뿌리 등에 함유되어 있는 DNJ(Dioxynojirimicin), 루틴, 식이섬유소, 칼슘, 철분, 아미노산 등의 유용약리 성분이 함유되어 있으며 홍삼, 산약, 천화분 등 한약재가 첨가되어 있고 특히 상황버섯 균사체가 배양되어 있어 베타글루칸 등에 의해 혈당강하 효과 및 콜레스테롤 저하 기능이 제고된 새로운 건강 기능성 상엽차이다.Hypoglycemic functional situation mushroom mycelium cultured leaf tea according to the present invention is useful pharmacological components such as DNJ (Dioxynojirimicin), rutin, dietary fiber, calcium, iron, amino acids contained in fruits, leaves, stems, roots, etc. It is a new health functional leaf tea with red ginseng, mountain medicinal herbs, cheonhwamin and other herbal medicines. Especially, mushroom mycelium is cultivated to improve blood sugar lowering effect and cholesterol lowering function by beta glucan.
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양 상엽차는 맛, 향, 색 등 기호성과 혈당강하 효과, 콜레스테롤 저하 등의 기능성이 뛰어나 건강 기능성 차류(분말, 액상) 및 각종 건강 기능성 식품, 기능성 화장품, 의약품 등의 원료로 활용할 수 있게 된다.Hypoglycemic functional situation mushroom mycelium cultured green tea according to the present invention is excellent in taste, flavor, color, palatability, hypoglycemic effect, cholesterol lowering function, and health functional teas (powder, liquid) and various health functional foods, functional cosmetics, medicines It can be utilized as a raw material such as.
Description
본 발명은 상목(뽕나무)의 잎, 열매, 줄기, 뿌리를 세척, 살청, 유념, 건조하는 기술, 상목(잎, 열매, 줄기, 뿌리 등)에 홍삼 등 유용 한약재를 첨가하여 상황버섯 균사체를 배양시키는 기술, 상기 상황버섯 균사체 배양 상엽차를 살균, 건조, 분쇄, 포장하는 기술로 구성되어 있다.The present invention is to cultivate the situation mushroom mycelium by adding a useful herbal medicine such as red ginseng to the leaves, berries, stems, roots, washing techniques, apricots, remarks, drying technology of the common tree (Mulberry) It consists of a technique for sterilizing, drying, pulverizing, and packaging the mushroom mycelium cultured upper leaf tea.
본 발명에서는 혈당강하 기능성 복분자차를 제조함에 있어 혈당강하 기능 및 콜레스테롤 저하 효과가 높은 상목의 잎, 열매, 줄기, 뿌리 등 상목의 식물 전체를 활용하여 각종 유용 약리성분을 최대로 활용할 수 있고 홍삼 등 한약재를 첨가시켜 상황버섯 균사체의 배지로 활용, 상황버섯 균사체를 배양함으로서 약리성이 극대화된 새로운 혈당강하 기능성 상엽차로 개발할 수 있는 기술에 관한 것이다.In the present invention, in the preparation of hypoglycemic functional bokbunja tea can take full advantage of various useful pharmacological components such as leaves, berries, stems, roots of the common tree having a high hypoglycemic function and cholesterol-lowering effect and maximize the use of various useful pharmacological components, such as red ginseng The present invention relates to a technology that can be developed as a new hypoglycemic functional leaf tea with maximum pharmacological properties by adding herbal medicine as a medium for mushroom mushroom mycelium and cultivating mushroom mushroom mycelium.
본 발명은 상목의 잎, 열매, 줄기, 뿌리 등 유용부위의 맛, 향, 색 등을 개선하기 위하여 120℃∼180℃에서 살청(덖음)하여 기호성을 향상시키는 기술, 보존성 개선을 위하여 70℃∼150℃에서 살청 및 건조하는 기술, 열수에 의한 용출성 개선을 위하여 세포조직을 파쇄하는 유념기술 등을 제조에 관한 물리적인 배경기술로 확립하고 상황버섯 균사체를 배양시키기 위하여 상실(오디)와 홍삼, 산약, 천화분 등 한방제재를 혼합한 배지를 제조하여 살균, 균사체 접종, 15℃∼35℃에서의 균사체 배양 등의 미생물학적 배양기술을 개발하여 본 발명의 기본적 기술로 확립하였다.The present invention is a technique for improving palatability by improving the taste, flavor, color, etc. of useful parts such as leaves, berries, stems, roots of the common tree at 120 ℃ to 180 ℃, 70 ℃ to improve the preservation In order to establish the physical background technology for manufacturing the technology of desalination and drying at 150 ℃ and the crushing of cellular tissues to improve the elution by hot water, and to culture the situation mushroom mycelium, A medium containing herbal medicines, such as powdered herbs and natural powders, was prepared, and microbiological culture techniques such as sterilization, inoculation of mycelium, and mycelium culture at 15 ° C. to 35 ° C. were developed and established as basic techniques of the present invention.
상목은 열매, 잎, 줄기, 뿌리 등으로 구성되어 있으며 각각 부위별로 함유된 유용성분이나 약리효과 및 맛, 향, 색 등에서 다소간 차이가 있으나 상실, 상엽의 혈당강하 성분 및 기호성이 주로 식용 약용으로 활용되고 있다. 본 발명에서는 유용 약리성분이 다량 함유되어 있으나 기호성 및 가공방법 등이 개발되지 않아 활용도가 떨어지는 잎, 줄기, 뿌리 등을 활용 홍삼 등의 한약제재와 혼합하여 균사체 배양배지로 이용하는 방법, 베타글루칸 성분에 의한 콜레스테롤 저하, 면역 등의 효과가 뛰어난 것으로 입증된 상황버섯 균사체를 상목 한약 혼합배지에서 배양하여 상황버섯 균사체에 의한 혈당강하, 콜레스테롤 저하 효과의 극대화 방법, 상실의 발효숙성 시에 활용하는 50% 정도의 설탕 등을 사용하지 않아 혈당강하 등의 기능성이 있으며 기호성과 보존성이 현저히 증가되는 가공방법에 관한 기술을 개발하고자 한다.It is composed of fruits, leaves, stems, roots, etc., but there are some differences in useful ingredients, pharmacological effects, tastes, aromas, colors, etc. contained in each part, but loss, upper blood sugar lowering component and palatability are mainly used for edible medicinal purposes. It is becoming. In the present invention, a useful pharmacological component is contained in a large amount, but since palatability and processing methods are not developed, the method is used as a mycelial culture medium by mixing with herbs, such as red ginseng, which has low utilization, such as leaves, stems, and roots. Strain mushroom mycelium, which has been proven to be effective in lowering cholesterol and immunity, is cultured in a mixed herbal medicine medium to maximize blood sugar lowering, cholesterol lowering effect, and 50% utilization of fermentation aging. It does not use sugar, etc., and it is to develop technology about processing method that has functionalities such as blood sugar drop and markedly increases palatability and preservation.
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양, 상엽차는 상목의 열매를 중심으로 하여 잎, 줄기, 뿌리 등 모든 유용성분을 활용할 수 있으며 홍삼, 산약, 천화분 등 한약재의 유용성분, 상황버섯 균사체의 콜레스테롤 저하 기능 및 면역 효과 등에 의해 생리활성 기능성이 극대화된 새로운 상엽차를 제공해 줄 수 있는 효과가 있다. 또한 기존의 상엽차의 기호성분인 당성분에 의한 과도한 단맛을 개선할 수 있으며 별도의 당성분 첨가 없이 보존성을 향상시킬 수 있어 건강 기능성 차 용도 이외에 건강 기능성 식품(음료, 주류, 장류, 조미료, 면류, 과자류 등), 건강 기능성 화장품(미백, 항산화 등), 의약품(혈당강하제, 콜레스테롤 저하제, 혈압강하제 등)의 원료로의 활용효과도 기대할 수 있게 된다.Hypoglycemic functional situation mushroom mycelium culture, the upper leaf tea according to the present invention can utilize all the useful components such as leaves, stems, roots, etc. centering on the fruit of the common tree There is an effect that can provide a new leaf tea with the maximum physiological activity by the lowering function and immune effect. In addition, it is possible to improve excessive sweetness by sugar component, which is a favorite ingredient of conventional green tea, and to improve the preservation without adding sugar component, so that it can be used for health functional foods (drinks, liquor, soy sauce, seasonings, noodles) , Sweets, etc.), health functional cosmetics (whitening, antioxidants, etc.), pharmaceuticals (hypoglycemic agents, cholesterol lowering agents, blood pressure lowering agents, etc.) can be expected to be used as raw materials.
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양 상엽차의 제조방법은 상엽(열매, 잎, 줄기, 뿌리)를 채취하여 정선, 세척, 살청, 유념, 건조하는 단계와 홍삼, 산약, 천화분 등 한약재를 첨가하는 단계, 상황버섯 균사체 종균을 접종하여 배양하는 단계, 상황버섯 균사체가 배양된 홍삼 등 한약재 함유 상엽차를 살균, 건조, 분쇄, 포장하는 단계로 구성되어 있다.The method for producing hypoglycemic-functional mushroom mycelium cultured upper leaf tea according to the present invention comprises extracting the upper leaves (fruit, leaves, stems, roots), and selecting herbs, washing, apricots, remarks, and drying herbs and herbal medicines such as red ginseng, acid powder, and natural flower. It consists of the step of adding, inoculating and incubating spawn mushroom mycelium spawn, sterilizing, drying, grinding, and packaging the herbal leaf tea containing red ginseng cultured with the situation mushroom mycelium.
본 발명의 구성에 관한 제조방법을 실시 예를 통하여 설명하면 다음과 같다.Referring to the manufacturing method according to the configuration of the present invention through the following examples.
1) 상황버섯 균사체를 PDB 배지에서 20℃∼35℃에서 3일∼7일간 진탕 암배양한다.1) Situary mushroom mycelium is shaken in culture PDB medium at 20-35 ℃ for 3-7 days.
2) 상실 10중량%∼50중량%, 상엽 10중량%∼50중량%, 상지 5중량%∼10중량%, 상백피 1중량%∼5중량%를 혼합한 후 홍삼 1중량%∼10중량%, 산약 1중량%∼10중량%, 천화분 1중량%∼10중량%를 첨가하여 50메쉬∼100메쉬로 분쇄한다.2) 1% by weight to 10% by weight of red ginseng, after mixing 10% by weight to 50% by weight, 10% by weight to 50% by weight of upper leaves, 5% to 10% by weight of upper limbs, and 1% to 5% by weight of lettuce; About 1% by weight to 10% by weight of acid, 1% by weight to 10% by weight of crushed powder is added, and pulverized into 50 mesh to 100 mesh.
3) 상기 2)의 상목, 한약재 혼합물을 120℃∼180℃의 팬에서 살청 후 유념시킨다.3) The mixture of medicinal herb and medicinal herb of 2) is agar after being soaked in a pan of 120 ° C to 180 ° C.
4) 상기 3)의 살청 및 유념된 상목 한약재 혼합물에 10중량%∼50중량%의 증류수를 넣고 살균하여 상기 1)의 상황버섯 균사체 배양액을 1중량%∼20중량% 접종한다.4) 10 wt% to 50 wt% of distilled water is sterilized in the apricot and mixed medicinal herb mixture of 3) to inoculate 1 to 20 wt% of the mushroom mushroom mycelium culture medium of 1) above.
5) 상기 4)를 5일∼12일간 20℃∼35℃에서 진탕 암배양한다.5) Shake 4) is carried out at 20 ° C to 35 ° C for 5 to 12 days.
6) 상기 5)를 90℃의 건조기에서 30분∼60분 살균 후 70℃에서 24시간∼48시간 수분함량 7% 이내가 되도록 건조한다.6) The above 5) is sterilized in a dryer at 90 ° C. for 30 minutes to 60 minutes and then dried at 70 ° C. so that the moisture content is within 7% for 24 hours to 48 hours.
7) 상기 6)을 100메쉬∼200메쉬로 분쇄하여 정선, 정량, 포장하여 완제품을 얻는다.7) Grind 6) above 100-200 mesh to select, quantify and package to obtain finished product.
[실험예]Experimental Example
본 발명에 의한 혈당강하 기능성 상황버섯 균사체 배양 상엽차를 20배수의 정제수를 가하여 100℃에서 8시간 열수추출 후 원심분리한 다음 상등액을 감압농축 동결건조하여 혈당강하 기능과 관련하여 α-glucosidase 저해활성 실험을 실시한 결과 65% 이상의 α-glucosidase 저해활성 효과가 있는 것으로 나타났다.Hypoglycemic functional status mushroom mycelium cultured supernatant according to the present invention was added to 20 times the purified water, and centrifuged after hot water extraction at 100 ° C for 8 hours, and then the supernatant was concentrated under reduced pressure to freeze the α-glucosidase activity in relation to the hypoglycemic function. Experimental results showed that the α-glucosidase inhibitory activity more than 65%.
본 발명에서의 혈당강하 기능성 상황버섯 균사체 배양 상엽차는는 상목의 열매, 잎, 줄기, 뿌리 등의 유용성분과 기호성, 홍삼, 산약, 천화분의 유용성과 기호성, 상황버섯 균사체에 의한 베타글루칸 등의 생리활성 성분이 함유되어 있어 혈당강하 기능 및 콜레스테롤 저하, 심혈관계의 질병 예방 및 치료 효과가 있으며 맛, 향, 색이 뛰어나고 기호성, 편의성 등이 개선된 차류(분말, 액상)을 제공해 줄 수 있다. 또한 상목의 잎, 줄기, 뿌리 등을 유용하게 활용할 수 있으며 혈당강하 효과, 면역 등 생리활성 기능이 있어 각종 기능성 식품, 기능성 화장품, 의약품 등의 원료로 활용할 수 있게 된다.Hypoglycemic-functional functional mushroom mycelium culture in the present invention is a useful component such as fruit, leaves, stems, roots and the like in the fruit of the common tree, the taste and taste of red ginseng, fungus, natural flower powder, bioactive components such as beta glucan by the situation mushroom mycelium It contains hypoglycemic function and cholesterol lowering, prevents and treats diseases of the cardiovascular system, and can provide tea (powder, liquid) with excellent taste, flavor, color, and improved taste and convenience. In addition, the leaves, stems, roots, etc. of the common tree can be usefully used, and have a physiological activity such as a hypoglycemic effect and immunity, and thus can be used as raw materials for various functional foods, functional cosmetics, and medicines.
..
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080003762A KR100959496B1 (en) | 2008-01-14 | 2008-01-14 | Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080003762A KR100959496B1 (en) | 2008-01-14 | 2008-01-14 | Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090078013A true KR20090078013A (en) | 2009-07-17 |
KR100959496B1 KR100959496B1 (en) | 2010-05-26 |
Family
ID=41336210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080003762A KR100959496B1 (en) | 2008-01-14 | 2008-01-14 | Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100959496B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101223746B1 (en) * | 2009-12-15 | 2013-01-23 | 이정호 | Mixed Tea Using Leaf, Root Bark and Fruit of Mulberry Tree |
CN103156938A (en) * | 2013-04-07 | 2013-06-19 | 贵州鸿德中药开发有限公司 | Hmong drug for treating diabetes mellitus |
CN103549600A (en) * | 2013-11-18 | 2014-02-05 | 唐海民 | Method for preparing pure natural nutritional immunity-improving health-care beverage |
KR20180061809A (en) * | 2016-11-30 | 2018-06-08 | 유정현 | Functional mulberry extract and manufacturing method thereof |
CN116649446A (en) * | 2023-06-14 | 2023-08-29 | 湖南省蚕桑科学研究所 | Phellinus linteus mycelium teabag with folium Mori Fuzhuan tea as fermentation material and its preparation method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030026140A (en) * | 2001-09-25 | 2003-03-31 | 김천환 | Mycellium production method of Cordyceps militaris, Inonotus obliquus and Phellinus linteus mushroom by use germinated grains and edible filber |
-
2008
- 2008-01-14 KR KR1020080003762A patent/KR100959496B1/en not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101223746B1 (en) * | 2009-12-15 | 2013-01-23 | 이정호 | Mixed Tea Using Leaf, Root Bark and Fruit of Mulberry Tree |
CN103156938A (en) * | 2013-04-07 | 2013-06-19 | 贵州鸿德中药开发有限公司 | Hmong drug for treating diabetes mellitus |
CN103549600A (en) * | 2013-11-18 | 2014-02-05 | 唐海民 | Method for preparing pure natural nutritional immunity-improving health-care beverage |
KR20180061809A (en) * | 2016-11-30 | 2018-06-08 | 유정현 | Functional mulberry extract and manufacturing method thereof |
CN116649446A (en) * | 2023-06-14 | 2023-08-29 | 湖南省蚕桑科学研究所 | Phellinus linteus mycelium teabag with folium Mori Fuzhuan tea as fermentation material and its preparation method |
Also Published As
Publication number | Publication date |
---|---|
KR100959496B1 (en) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103315362B (en) | Poria cocos solid state fermentation functional beverage and its preparation method | |
KR101177245B1 (en) | Dietary supplement containing fermented rice bran of brown rice and manufacturing method thereof | |
KR100959496B1 (en) | Hypoglycemic Functional Situation Mushroom Mycelium Cultured Leaf Tea | |
KR100907037B1 (en) | Cultivation method of Ganoderma lucidum or shiitake mushroom mycelium containing green tea ingredients and food prepared using the same | |
WA et al. | Bioactive potential of some fascinating edible mushrooms Macrolepiota, Russula, Amanita, Vovariella and Grifola as a treasure of multipurpose therapeutic natural product | |
CN106616109A (en) | Preparation method for ganoderma lucidum beverage | |
KR102211523B1 (en) | Pills for health foods and methods for manufacturing same | |
CN102578528A (en) | A health-care black soybean bean drum containing Chinese herbal medicine formula and its production process | |
KR20170065452A (en) | Lotus tea beverage and manufacturing method thereof | |
CN102578494B (en) | Health black soybean fermented soya beans containing Chinese herbal medicine formula and production process thereof | |
KR100775274B1 (en) | Manufacturing method of red ginseng hwancheongjang | |
KR100959497B1 (en) | Antioxidant Functional Cordyceps Mycelium Culture Bokbunja Tea | |
KR102107424B1 (en) | Fermented pumpkin tea and manufacturing method thereof | |
KR101586053B1 (en) | method manufacturing Powder of Cudrania tricuspidata | |
KR101508720B1 (en) | Preparation Method for Soy Sauce Comprising Gastrodia elata and Lentinula edodes | |
CN106348899A (en) | Culture material for pleurotus eryngii and preparation method of culture material | |
KR102616727B1 (en) | Method of manufacturing high-protein phellinus linteus alcoholic drinks and phellinus linteus alcoholic drinks manufactured by the same | |
KR102575880B1 (en) | Mixed mycelium with enhanced beta-glucan content and manufacturing method thereof | |
CN109730216A (en) | Stems of dragon fruits gel stoste extracting method | |
KR102699337B1 (en) | Immune-boosting composition comprising Angelica extract and Aster glehni extract | |
CN104187608B (en) | Health food with hypoglycemic activity and preparation method thereof | |
KR102712026B1 (en) | Manufacturing method for composition mycelia, composition mycelia, manufacturing method for material comprising beta-glucan | |
CN102578539B (en) | Health-care black bean salt black bean containing Chinese herbal medicine formula and production process thereof | |
CN102578533B (en) | Health black soybean fermented soya beans containing Chinese herbal medicine formula and production process thereof | |
KR101917536B1 (en) | Moringa soybean paste including Chaga mushroom and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20080114 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20090611 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20091208 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20100503 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20100514 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20100514 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |